Patents by Inventor Shin-San Michael Su

Shin-San Michael Su has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS
    Publication number: 20240071588
    Abstract: Methods of treating and evaluating subjects having neoactive mutants are described herein.
    Type: Application
    Filed: January 13, 2023
    Publication date: February 29, 2024
    Inventors: Lenny Dang, Valeria Fantin, Stefan Gross, Hyun Gyung Jang, Shengfang Jin, Francesco G. Salituro, Jeffrey O. Saunders, Shin-San Michael Su, Katharine Yen
  • Pyruvate kinase activators for use in therapy
    Patent number: 11793806
    Abstract: Described herein are methods for using compounds that activate pyruvate kinase.
    Type: Grant
    Filed: April 2, 2021
    Date of Patent: October 24, 2023
    Assignee: Agios Pharmaceuticals, Inc.
    Inventors: Shin-San Michael Su, Lenny Dang
  • PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY
    Publication number: 20210220351
    Abstract: Described herein are methods for using compounds that activate pyruvate kinase.
    Type: Application
    Filed: April 2, 2021
    Publication date: July 22, 2021
    Inventors: Shin-San Michael Su, Lenny Dang
  • PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY
    Publication number: 20200289502
    Abstract: Described herein are methods for using compounds that activate pyruvate kinase.
    Type: Application
    Filed: March 17, 2020
    Publication date: September 17, 2020
    Inventors: Shin-San Michael Su, Lenny Dang
  • METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS
    Publication number: 20200281501
    Abstract: Methods of treating and evaluating subjects having neoactive mutants are described herein.
    Type: Application
    Filed: February 14, 2020
    Publication date: September 10, 2020
    Inventors: Lenny Dang, Valeria Fantin, Stefan Gross, Hyun Gyung Jang, Shengfang Jin, Francesco G. Salituro, Jeffrey O. Saunders, Shin-San Michael Su, Katharine Yen
  • Methods for diagnosing IDH-mutant cell proliferation disorders
    Patent number: 10711314
    Abstract: Methods of diagnosing subjects having a cell proliferation-related disorder or suspected of having a cell proliferation-related disorder associated with mutant IDH enzymes with 2HG neoactivity.
    Type: Grant
    Filed: April 26, 2018
    Date of Patent: July 14, 2020
    Assignee: Agios Pharmaceuticals, Inc.
    Inventors: Leonard Luan C. Dang, Stefan Gross, Hyun Gyung Jang, Shengfang Jin, Shin-San Michael Su, Craig Thompson
  • Pyruvate kinase activators for use in therapy
    Patent number: 10632114
    Abstract: Described herein are methods for using compounds that activate pyruvate kinase.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: April 28, 2020
    Assignee: Agios Pharmaceuticals, Inc.
    Inventors: Shin-San Michael Su, Lenny Dang
  • Methods and compositions for cell-proliferation-related disorders
    Patent number: 10610125
    Abstract: Methods of treating and evaluating subjects having neoactive mutants are described herein.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: April 7, 2020
    Assignee: Agios Pharmaceuticals, Inc.
    Inventors: Lenny Dang, Valeria Fantin, Stefan Gross, Hyun Gyung Jang, Shengfang Jin, Francesco G. Salituro, Jeffrey O. Saunders, Shin-San Michael Su, Katharine Yen
  • METHOD FOR TREATING CELL PROLIFERATION RELATED DISORDERS
    Publication number: 20190276894
    Abstract: Methods of treating and evaluating subjects having neoactive mutants of IDH (e.g., IDH1 or IDH2).
    Type: Application
    Filed: April 26, 2018
    Publication date: September 12, 2019
    Inventors: Leonard Luan C. Dang, Stefan Gross, Hyun Gyung Jang, Shengfang Jin, Shin-San Michael Su, Craig Thompson
  • PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY
    Publication number: 20180338970
    Abstract: Described herein are methods for using compounds that activate pyruvate kinase.
    Type: Application
    Filed: April 27, 2018
    Publication date: November 29, 2018
    Inventors: Shin-San Michael Su, Lenny Dang
  • Method for treating cell proliferation related disorders
    Patent number: 9982309
    Abstract: Methods of treating and evaluating subjects having neoactive mutants of IDH (e.g., IDH1 or IDH2).
    Type: Grant
    Filed: August 16, 2016
    Date of Patent: May 29, 2018
    Assignee: AGIOS PHARMACEUTICALS, INC.
    Inventors: Leonard Luan C. Dang, Stefan Gross, Hyun Gyung Jang, Shengfang Jin, Shin-San Michael Su, Craig Thompson
  • Pyruvate kinase activators for use in therapy
    Patent number: 9980961
    Abstract: Described herein are methods for using compounds that activate pyruvate kinase.
    Type: Grant
    Filed: May 1, 2017
    Date of Patent: May 29, 2018
    Assignee: AGIOS PHARMACEUTICALS, INC.
    Inventors: Shin-San Michael Su, Lenny Dang
  • METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS
    Publication number: 20170325708
    Abstract: Methods of treating and evaluating subjects having neoactive mutants are described herein.
    Type: Application
    Filed: May 8, 2017
    Publication date: November 16, 2017
    Applicant: Agios Pharmaceuticals, Inc.
    Inventors: Lenny Dang, Valeria Fantin, Stefan Gross, Hyun G. Jang, Shengfang Jin, Francesco G. Salituro, Jeffrey O. Saunders, Shin-San Michael Su, Katharine Yen
  • PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY
    Publication number: 20170290825
    Abstract: Described herein are methods for using compounds that activate pyruvate kinase.
    Type: Application
    Filed: May 1, 2017
    Publication date: October 12, 2017
    Inventor: Shin-San Michael Su
  • Pyruvate kinase activators for use in therapy
    Patent number: 9682080
    Abstract: Described herein are methods for using compounds that activate pyruvate kinase.
    Type: Grant
    Filed: October 19, 2015
    Date of Patent: June 20, 2017
    Assignee: AGIOS PHARMACEUTICALS, INC
    Inventor: Shin-San Michael Su
  • METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS
    Publication number: 20170044620
    Abstract: Methods of treating and evaluating subjects having neoactive mutants of IDH (e.g., IDH1 or IDH2).
    Type: Application
    Filed: August 16, 2016
    Publication date: February 16, 2017
    Inventors: Leonard Luan C. Dang, Stefan Gross, Hyun Gyung Jang, Shengfang Jin, Shin-San Michael Su, Craig Thompson
  • Methods and compositions for cell-proliferation-related disorders
    Patent number: 9434979
    Abstract: Methods of treating and evaluating subjects having neoactive mutants of IDH (e.g., IDH1 or IDH2).
    Type: Grant
    Filed: April 20, 2012
    Date of Patent: September 6, 2016
    Inventors: Shin-San Michael Su, Lenny Dang, Stefan Gross, Shengfang Jin, Valeria Fantin
  • Pyruvate kinase activators for use in therapy
    Patent number: 9404081
    Abstract: Described herein are methods for using compounds that activate pyruvate kinase.
    Type: Grant
    Filed: May 3, 2012
    Date of Patent: August 2, 2016
    Assignee: AGIOS PHARMACEUTICALS, INC.
    Inventor: Shin-San Michael Su
  • PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY
    Publication number: 20160106742
    Abstract: Described herein are methods for using compounds that activate pyruvate kinase.
    Type: Application
    Filed: October 19, 2015
    Publication date: April 21, 2016
    Inventor: Shin-San Michael Su
  • METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS
    Publication number: 20150240286
    Abstract: Methods of treating and evaluating subjects having neoactive mutants of IDH (e.g., IDH1 or IDH2).
    Type: Application
    Filed: October 2, 2014
    Publication date: August 27, 2015
    Applicant: AGIOS PHARMACEUTICALS, INC
    Inventors: Leonard Luan C Dang, Stefan Gross, Hyun Gyung Jang, Shengfang Jin, Shin-San Michael Su, Craig Thompson